Pharmaceuticals

Global Omega 3 Prescription Drugs Market Size Projected to Reach $2.55 Billion During the Forecast Period

November 10, 2025 by Marketing Posting

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

By How Much Is The Omega 3 Prescription Drugs Market Expected To Expand Between 2025 And 2029?

The omega 3 prescription drugs market size has demonstrated robust growth over recent years. It is anticipated to expand from $1.61 billion in 2024 to $1.75 billion in 2025, achieving a compound annual growth rate (CAGR) of 8.4%. The historical expansion of this market can be attributed to factors such as increased health awareness, advances in clinical research, a greater emphasis on cardiovascular health, rising medical recommendations, and improved management of chronic diseases.

The omega 3 prescription drugs market size is set for substantial growth in the upcoming years. It is predicted to expand to $2.55 billion by 2029, achieving a compound annual growth rate (CAGR) of 9.9%. This expansion during the forecast period is primarily due to broadened indications, shifting consumer preferences, specific health solutions, individualized medicine, and an increase in clinical evidence. Key trends anticipated in this period include personalized health solutions, a wider range of treatable health conditions, new and improved formulations, the increasing demand for health supplements, and the integration of health apps and wearables.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=8091&type=smp

Which Drivers Are Impacting The Omega 3 Prescription Drugs Market?

The increasing prevalence of cardiovascular diseases (CVDs) is anticipated to fuel the expansion of the omega-3 prescription drug market. Elevated blood triglyceride levels, which are a fatty substance, are associated with an increased likelihood of cardiovascular conditions; omega-3 supplements assist in managing and reducing these levels. For example, the World Health Organization (WHO) reported in 2022 that cardiovascular diseases (CVDs) continued to be the primary cause of death globally, accounting for approximately 20.5 million deaths, representing nearly a third of all worldwide fatalities. This figure signifies an increase when put against the earlier estimate of 121 million CVD-related deaths. Consequently, the growing incidence of cardiovascular diseases (CVDs) propels the expansion of the omega-3 prescription drug market.

What Are The Major Segments Identified In The Omega 3 Prescription Drugs Market?

The omega 3 prescription drugs market covered in this report is segmented –

1) By Drug Type: Vascepa, Lovaza, Other Type

2) By Application Type: Hypertriglyceridemia, Other Application Type

3) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy

Subsegments:

1) By Vascepa: Pure EPA (Eicosapentaenoic Acid) Formulation, Indications For Cardiovascular Risk Reduction

2) By Lovaza: Combination Of EPA And DHA (Docosahexaenoic Acid), Indications For Hypertriglyceridemia Management

3) By Other Types: Epanova (Omega-3 Carboxylic Acids), Omega-3 Formulations In Clinical Trials, Other Prescription Omega-3 Products

What Are The Latest Industry Trends Transforming The Omega 3 Prescription Drugs Market?

Product innovation has become a significant and growing trend within the omega-3 prescription drug market. Key companies involved in producing omega-3 drugs are prioritizing the development of new products to solidify their market presence. For example, in October 2022, the European Commission authorized plant-based omega-3 products from DSM for use as substitutes for fish and animals across the EU. DSM states that this product improves the nutritional profile of plant-based foods and allows for the creation of animal-based fish products that are comparable to current options. This omega-3 supplement can be utilized to enhance the nutritional value of various items without negatively affecting the marine ecosystem.

Which Key Players Are Driving Competition In The Omega 3 Prescription Drugs Market?

Major companies operating in the omega 3 prescription drugs market include Ionis Pharmaceuticals, Sarepta Therapeutics, Alnylam Pharmaceuticals, Wave Life Sciences, Dyno Therapeutics, BioNTech SE, Moderna Therapeutics, Silence Therapeutics, Arrowhead Pharmaceuticals, ProQR Therapeutics, Regulus Therapeutics, Stoke Therapeutics, Editas Medicine, Beam Therapeutics, Miragen Therapeutics, Biogen Inc., Pfizer Inc., GlaxoSmithKline plc, Arbutus Biopharma, Sanofi S.A., Benitec Biopharma, CRISPR Therapeutics, Dicerna Pharmaceuticals, Translate Bio, PepGen Inc., Sirnaomics Inc., Sterna Biologicals, Genevant Sciences, Genzyme Corporation.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/omega-3-prescription-drugs-global-market-report

Which Region Currently Holds The Largest Share Of The Omega 3 Prescription Drugs Market?

North America was the largest region in the omega 3 prescription drugs market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the omega 3 prescription drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Omega 3 Prescription Drugs Market Report:

https://www.thebusinessresearchcompany.com/customise?id=8091&type=smp

Browse Through More Reports Similar to the Global Omega 3 Prescription Drugs Market 2025, By The Business Research Company

Drug Delivery Devices Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/drug-delivery-devices-global-market-report

Drugs For Immunotherapy Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/drugs-for-immunotherapy-global-market-report

Drugs For Hormonal Replacement Therapy Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/drugs-for-hormonal-replacement-therapy-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795